Evidence map›Paper›PMID 24449860›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Toxin Kid uncouples DNA replication and cell division to enforce retention of plasmid R1 in Escherichia coli cells.

Belén Pimentel, Radhika Nair, Camino Bermejo-Rodríguez, Mark A Preston, Chukwuma A Agu, Xindan Wang, Juan A Bernal, David J Sherratt, Guillermo de la Cueva-Méndez

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Belén PimentelMedical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Cambridge CB2 0XZ, United Kingdom.
Radhika Nair
Camino Bermejo-Rodríguez
Mark A Preston
Chukwuma A Agu
Xindan Wang
Juan A Bernal
David J Sherratt
Guillermo de la Cueva-Méndez
Hutchison/MRC Research Centre · GBMedical Research Council · GBUniversity of Oxford · GBSpanish National Centre for Cardiovascular Research · ES

Funding

Medical Research Council MC_U105365008Wellcome Trust WT099204AIA
6 · The paper itself

Abstract

Worldwide dissemination of antibiotic resistance in bacteria is facilitated by plasmids that encode postsegregational killing (PSK) systems. These produce a stable toxin (T) and a labile antitoxin (A) conditioning cell survival to plasmid maintenance, because only this ensures neutralization of toxicity. Shortage of antibiotic alternatives and the link of TA pairs to PSK have stimulated the opinion that premature toxin activation could be used to kill these recalcitrant organisms in the clinic. However, validation of TA pairs as therapeutic targets requires unambiguous understanding of their mode of action, consequences for cell viability, and function in plasmids. Conflicting with widespread notions concerning these issues, we had proposed that the TA pair kis-kid (killing suppressor-killing determinant) might function as a plasmid rescue system and not as a PSK system, but this remained to be validated. Here, we aimed to clarify unsettled mechanistic aspects of Kid activation, and of the effects of this for kis-kid-bearing plasmids and their host cells. We confirm that activation of Kid occurs in cells that are about to lose the toxin-encoding plasmid, and we show that this provokes highly selective restriction of protein outputs that inhibits cell division temporarily, avoiding plasmid loss, and stimulates DNA replication, promoting plasmid rescue. Kis and Kid are conserved in plasmids encoding multiple antibiotic resistance genes, including extended spectrum β-lactamases, for which therapeutic options are scarce, and our findings advise against the activation of this TA pair to fight pathogens carrying these extrachromosomal DNAs.

Indexed as

Base SequenceBlotting, WesternCell DivisionDNA ReplicationDrug Resistance, BacterialEscherichia coliEscherichia coli ProteinsMicroscopy, ElectronMolecular Sequence DataOligonucleotidesR FactorsSequence Analysis, DNAEscherichia coli Proteinskid toxin protein, E coli plasmid R1OligonucleotidesmRNA interferaseparDPemKplasmid stabilityRNase

Identifiers

PMID24449860
PMCPMC3932891
OpenAlexW2035078336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.